1 / 10

Global Toolkit on Treatment Demand Data State of Progress Michael Donmall

N ational D rug E vidence C entre. Global Toolkit on Treatment Demand Data State of Progress Michael Donmall (Co-ordinator Joint Project). N ational D rug E vidence C entre. Background. TDI – EMCDDA-Pompidou Group Protocol European harmonisation Potential for wider application

bisa
Télécharger la présentation

Global Toolkit on Treatment Demand Data State of Progress Michael Donmall

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. National Drug Evidence Centre Global Toolkit on Treatment Demand Data State of Progress Michael Donmall (Co-ordinator Joint Project)

  2. National Drug Evidence Centre Background • TDI – EMCDDA-Pompidou Group Protocol • European harmonisation • Potential for wider application • GAP – improve global information on drug consumption • Governments committed to measurable results demand reduction by 2008 • Need reliable & systematic data at global level • Assist governments in compiling comparable data • Collect, summarise, analyse & report data to Commission Narcotic Drugs • INRA • UNODC/ EMCDDA 2003 – joint initiative established • Define workable & practical toolkit • Harmonisation - comparative international work

  3. National Drug Evidence Centre Common issues that need structured guidance over wide area • Definitional issues • Treatment, cases, episodes, core data set • Technical matters • Quality control, double counting, data capture • Development • Need and purpose • Implementation • in context of local, national & international needs • Analysis & dissemination • Clarity • Importance of being a collaborative exercise

  4. National Drug Evidence Centre Global Workshop on Treatment Demand Indicators, Vienna 2003 • Opportunity to discuss & share experiences of practicalities of implementing Treatment Information Systems • Explore basic rationale behind collection of such information • Role and utility • Strengths and limitations • As epidemiological tool • In performance management • Define in broad terms the requirements of a global toolkit

  5. National Drug Evidence Centre • Project Team: • Michael Donmall National Drug Evidence Centre, Manchester, UK • Linda Montanari EMCDDA, Portugal • Stefano Berterame UNODC. Austria • Meeting Participants: • Stefano Berterame UNODC, Austria • Luis Caris CICAD, Chile • Michael Donmall National Drug Evidence Centre, UK • Leigh Henderson SAMHSA, USA • Douglas Ken-Garfield CAREC, Republic of Trinidad and Tobago • Peter Lawrinson National Drug and Alcohol Research Centre, Australia • Riku Lehtovuori UNODC, Austria • Jean Long Pompidou Group. Ireland • Linda Montanari EMCDDA, Portugal • Visweswaran Navaratnam National Centre for Drug Research, Malaysia • Kamran Niaz UNODC, Turkey • Isidore S. Obot WHO, Switzerland • Charles Parry SENDU, South Africa • Luis Royuela Morales Plan Nacional sobre Drogas, Spain • Brian Rush Centre for Addiction and Mental Health, Canada • Bela Studnikova Drug Epidemiology Headquarters, Czech Republic • Fayzel Sulliman Dr Idrice Goomany Centre Mauritius • Juana Tomas-Rossello UNODC, Austria • Matthew Warner-Smith UNODC, Egypt

  6. EMCDDA Project CT.03.ENL.209 FINAL REPORT & PROPOSED OUTLINE GLOBAL TOOLKIT FOR THE MEASUREMENT OF DRUG TREATMENT DEMAND BACKGROUND MATERIAL FOR THE DEVELOPMENT OF A TOOLKIT ON DATA COLLECTION REGARDING DRUG TREATMENT DEMAND IN THE EUROPEAN MEMBER STATES AND IN THE ACCEDING AND CANDIDATE COUNTRIES INCLUDING MEETING REPORT OF THE GLOBAL WORKSHOP ON TREATMENT DEMAND INDICATORS VIENNA INTERNATIONAL CENTRE, DECEMBER 2003

  7. National Drug Evidence Centre Proposed Toolkit Structure • 1 Introduction • 1.1 Aims • 1.2 Readership • 1.3 Main Features & Roadmap • 2 Overview: reasons for collecting drug treatment data • 2.1 Why a system of treatment data collection is useful • For epidemiological and/or performance management • As an indirect indicator of trends in problem drug use • For identifying patterns of drug use • As a basis for other methodologies (eg incidence) • For policy and advocacy • To identify patterns of use of services • For plans and service evaluation • Other purposes • 2.2 Limitations

  8. National Drug Evidence Centre Proposed Toolkit Structure • Building your foundation • 3.1 Scoping – comparison between systems • 3.2 Information, Needs and Resources Assessment (INRA) • 3.3 Organisational Issues • Gaining political support • Identifying stakeholders • Location • Funding • 3.4 Inventory of services & describe treatment system • 4 Data to be collected • 4.1 Guiding principles • 4.2 The core item list • 4.3 Core Definitions • Case definition • Treatment, treatment demand, type, episode • Item definitions and valid codes • 4.4 Core information requirement at a global level • 4.5 Case Studies

  9. National Drug Evidence Centre Proposed Toolkit Structure • 5 Implementing a Treatment Demand Indicator System • 5.1 Planning and development • People/ network issues • Procedures • Technical Issues • Ethical Issues • Planning use of data • 5.2 Data collection • Establishing process • Data checking, validation & ongoing audit • 5.3 Data quality & Coverage • 5.5 Case Studies • 6 Analysing and Reporting on the Results • 6.1 Data Analysis & Interpretation • 6.2 Reporting • 6.3 Case Studies

  10. National Drug Evidence Centre Proposed Toolkit Structure • 7 Maintenance & Evaluation • 7.1 Maintenance • 7.2 Evaluation • Glossary • Bibliography • Appendix • A Sample Materials • Data collection sheets • Reports • Validation rules • B Frequently Asked Questions (FAQs) • C Links to relevant Web Addresses • D Key Toolkit Markers (PowerPoint)

More Related